Report #2837766

Received Apr 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: MD
Recovered: Unknown
Vaccinated: Apr 15, 2025
Onset: Apr 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPHEPBIP	DTAP + HEPB + IPV (PEDIARIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	PE24L	—

Symptoms (1)

Expired product administered

Symptom narrative

Pediarix expired with expiration date April 11, 2025 was administered to a patient in April 15, 2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 14-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number PE24L, expiry date 11-APR-2025) for prophylaxis. On 15-APR-2025, the patient received Pediarix. On 15-APR-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: Pediarix expired with expiration date April 11, 2025 was administered to a patient in April 15, 2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 16-APR-2025 Medical assistant called to report a Pediarix expired with expiration date April 11, 2025 was administered to a patient in April 15, 2025 which led to expired vaccine used.